HomeMarket NewsFDA Probe On China-Made Syringes: Becton Dickinson Boosts US Syringe Output Following...

FDA Probe On China-Made Syringes: Becton Dickinson Boosts US Syringe Output Following Concerns

Actionable Trade Ideas

always free




FDA Investigation Sparks Becton Dickinson to Ramp Up US Syringe Production

pharma lab worker ai 14

FDA Concerns Prompt Action

In response to FDA concerns over the quality of China-made syringes, Becton Dickinson And Co (BDX) announced an escalation in U.S. syringe output. The FDA advised against the use of selected Chinese syringes due to ongoing quality investigations.

Boosting US Production

BD Medication Delivery Solutions President, Eric Borin, assured, β€œBD has the capacity and is escalating U.S. production to meet rising syringe demand. Following the FDA’s safety alert in November, BD has bolstered syringe manufacturing in Nebraska and Connecticut to meet customer requirements.”

Quality Concerns Unearthed

The FDA’s November 2023 announcement alerted consumers and healthcare bodies to potential issues with plastic syringes manufactured in China. Concerns include device failures such as leaks and breakages, sparking an evaluation of syringe quality from Chinese manufacturers.

Violation Citations

Three Chinese companies – Jiangsu Shenli Medical Production Co. Ltd, Medline Industries LP, and Sol-Millennium Medical Inc. – faced regulatory citations for syringe manufacturing violations. The FDA expressed ongoing unease regarding the consistency and performance of Chinese-made syringes.

Robust FDA Investigation

An extensive review by CNBC revealed over 4,000 reports of plastic syringe issues in 2023, though not limited to China. The FDA acknowledged data limitations due to incomplete information and potential under-reporting, emphasizing the gravity of their probe.

Share Performance

As of Thursday’s close, BDX shares were up 1.18% at $240.68. The market’s reaction underscores investor confidence in Becton Dickinson’s responsiveness to regulatory concerns and commitment to patient care.

Illustration of Pharma lab worker created with MidJourney.


Swing Trading Ideas and Market Commentary

Need some new swing ideas? Get free weekly swing ideas and market commentary from Jonathan Bernstein here: Swing Trading.

Explore More

Weekly In-Depth Market Analysis and Actionable Trade Ideas

Get institutional-level analysis and trade ideas to take your trading to the next level, sign up for free and become apart of the community.